< Back to companies
hema.to
München, Germany
hema.to provides fully automated, AI-powered diagnosis recommendations for blood cancer from flow cytometry data. Diagnosticians using hema.to not only showed a higher speed but could also achieve an increase in quality.
Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2021
- Website
- www.hema.to/
Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join nowWhat do you think of hema.to?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join now